Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | Dr. Gregory RussottiChief Technology & Manufacturing Officer | -2,58k | 5,77k | Vendita | 2,23 | 605,09k | -0,43% |
| 2026-06-12 | Mr. Douglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary | -1,65k | 3,69k | Vendita | 2,23 | 505,09k | -0,33% |
| 2026-06-11 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | -13,85k | 31,02k | Sale to Issuer | 2,24 | 3,67M | -0,38% |
| 2026-06-11 | Dr. Chad A. CowanChief Scientific Officer | -358,00 | 801,92 | Sale to Issuer | 2,24 | 228,59k | -0,16% |
| 2026-06-05 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | -463,00 | 986,19 | Sale to Issuer | 2,13 | 3,68M | -0,01% |
| 2026-06-08 | Dr. Gregory RussottiChief Technology & Manufacturing Officer | -524,00 | 1,11k | Vendita | 2,11 | 607,68k | -0,09% |
| 2026-06-08 | Mr. Douglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary | -249,00 | 525,64 | Vendita | 2,11 | 506,75k | -0,05% |
| 2026-05-15 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | -31,17k | 72,94k | Sale to Issuer | 2,34 | 3,68M | -0,84% |
| 2026-05-04 | Mr. Douglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary | -264,00 | 618,02 | Vendita | 2,34 | 507,00k | -0,05% |
| 2026-04-01 | Dr. Chad A. CowanChief Scientific Officer | -1,37k | 2,99k | Sale to Issuer | 2,19 | 227,72k | -0,60% |
| 2026-03-12 | Mr. Douglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary | -7,04k | 17,95k | Vendita | 2,55 | 507,26k | -1,37% |
| 2026-03-12 | Dr. Gregory RussottiChief Technology & Manufacturing Officer | -10,08k | 25,68k | Vendita | 2,55 | 608,20k | -1,63% |
| 2026-03-11 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | -55,40k | 151,23k | Sale to Issuer | 2,73 | 1,26M | -4,22% |
| 2026-03-11 | Dr. Chad A. CowanChief Scientific Officer | -1,43k | 3,91k | Sale to Issuer | 2,73 | 224,44k | -0,63% |
| 2026-03-09 | Dr. Gregory RussottiChief Technology & Manufacturing Officer | -479,00 | 1,21k | Vendita | 2,54 | 379,78k | -0,13% |
| 2026-03-09 | Mr. Douglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary | -247,00 | 626,39 | Vendita | 2,54 | 297,93k | -0,08% |
| 2026-03-06 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | -463,00 | 1,19k | Sale to Issuer | 2,56 | 660,00k | -0,07% |
| 2026-02-13 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | -31,17k | 54,55k | Sale to Issuer | 1,75 | 659,38k | -4,51% |
| 2026-02-03 | Mr. Douglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary | -323,00 | 588,51 | Vendita | 1,82 | 297,30k | -0,11% |
| 2026-01-02 | Dr. Chad A. CowanChief Scientific Officer | -1,61k | 1,60k | Sale to Issuer | 1,00 | 221,00k | -0,72% |
| 2025-12-22 | Dr. Chad A. CowanChief Scientific Officer | 58,06k | 49,25k | Acquisto | 0,85 | 217,96k | 36,31% |
| 2025-12-12 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | 52,00k | 30,35k | Acquisto | 0,58 | 617,19k | 9,20% |
| 2025-12-10 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | -463,00 | 243,54 | Sale to Issuer | 0,53 | 565,19k | -0,08% |
| 2025-12-08 | Mr. Douglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary | -257,00 | 136,72 | Vendita | 0,53 | 301,37k | -0,09% |
| 2025-12-08 | Dr. Gregory RussottiChief Technology & Manufacturing Officer | -526,00 | 279,83 | Vendita | 0,53 | 350,26k | -0,15% |
| 2025-11-20 | Dr. Chad A. CowanChief Scientific Officer | -5,46k | 2,74k | Vendita | 0,50 | 159,90k | -3,30% |
| 2025-11-19 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | 35,00k | 17,33k | Acquisto | 0,50 | 564,56k | 6,61% |
| 2025-11-17 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | -32,46k | 14,74k | Vendita | 0,45 | 529,56k | -5,77% |
| 2025-11-03 | Mr. Douglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary | -292,00 | 171,11 | Vendita | 0,59 | 296,07k | -0,10% |
| 2025-09-08 | Mr. Douglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary | -263,00 | 131,50 | Vendita | 0,50 | 295,42k | -0,09% |
| 2025-09-08 | Dr. Gregory RussottiChief Technology & Manufacturing Officer | -539,00 | 269,50 | Vendita | 0,50 | 349,28k | -0,15% |
| 2025-09-08 | Dr. Brent PfeiffenbergerPresident, CEO & Chairman | -488,00 | 244,00 | Vendita | 0,50 | 488,66k | -0,10% |
| 2025-08-04 | Mr. Douglas CarrSenior VP of Finance & Operations, Principal Financial Officer and Secretary | -296,00 | 158,06 | Vendita | 0,53 | 294,81k | -0,10% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
